COLAL-PRED Alizyme.

Article Details

Citation
Copy to clipboard

Hanauer SB, Sparrow M

COLAL-PRED Alizyme.

Curr Opin Investig Drugs. 2004 Nov;5(11):1192-7.

PubMed ID
15573870 [ View in PubMed
]
Abstract

COLAL-PRED (prednisolone sodium metasulfobenzoate), which is targeted to the colon by COLAL colonic drug delivery technology, is being developed by Alizyme for the potential treatment of inflammatory bowel disease. Alizyme expect to initiate a phase III trial in 2005.

DrugBank Data that Cites this Article

Drugs